Free shipping on orders above ₹499  ·  Not sure which product? Take the quiz →
Complete Guide · 8 Articles · Chronic Gastritis

Chronic Gastritis in India:

What the Endoscopy Data Shows, and What Healing Actually Requires

Most people with gastritis are given a PPI and told to avoid spicy food. Neither addresses the inflammation that's actually damaging the lining. The 8 articles in this guide cover what gastritis is, what causes it, how the stomach repairs itself — and what the science says about supporting recovery.

📋 Clinical author: Merlin Annie Raj, RD 📅 Published March 2026 🔬 Based on 20,363-person survey 📚 8 articles · 4 layers
24%
gastritis confirmed on scope
86%
had a significant finding
62%
H. pylori positive (primary driver)
37%
symptomatic for 3+ years
20,363
Indians surveyed
TL;DR — What this guide covers

Chronic gastritis — persistent inflammation of the stomach lining — is one of the most under-explained diagnoses in Indian gut health. In TumGard's survey, 24% of buyers who had an endoscopy received a confirmed gastritis diagnosis, and 86% had a clinically significant finding of some kind — only 5.8% came back normal. The primary driver in most cases was H. pylori infection, present in 62% of the same cohort. The 8 articles in this guide move from what gastritis actually is and how to recognise its symptoms, through the exact mechanism by which H. pylori causes and sustains mucosal inflammation, to what the stomach lining repair process requires — and what the peer-reviewed evidence says about supporting it.

What is chronic gastritis — and how do you recognise it?

Most people with gastritis are never told exactly what the diagnosis means. Their endoscopy report says "mild antral gastritis" and their doctor writes a PPI prescription. These two articles explain what the condition is biologically, and the symptom patterns that separate it from ordinary indigestion.

What it is
What Is Chronic Gastritis? The Diagnosis Most Indians Don't Fully Understand
What the inflammation actually looks like at the mucosal level — goblet cell damage, mucus layer thinning, and why a PPI doesn't address any of it.
Symptoms
Gastritis Symptoms: When Your Stomach Pain Is More Than Indigestion
Seven symptom patterns that point to gastritis rather than ordinary acidity — including early satiety, the one sign most patients attribute to something else entirely.

The H. pylori–gastritis connection — and why it doesn't resolve on antacids

In India's endoscopy data, gastritis and H. pylori are not two separate problems — they are the same problem seen from two angles. H. pylori is the primary driver of chronic active gastritis. These articles cover the exact mechanism, and what reversing it actually requires.

The cause
How H. Pylori Causes Chronic Gastritis — The Exact Mechanism
From bacterial colonisation to NF-kB activation to goblet cell destruction — the step-by-step process that turns an H. pylori infection into a chronically inflamed stomach lining.
Recovery
Can Gastritis Be Reversed? What the Evidence Actually Shows
The short answer is yes — but only if the underlying driver is addressed and the lining is given the right conditions to repair. What recovery looks like, and how long it takes.

The endoscopy data behind this guide

The most clinically significant data comes from the endoscopy sub-cohort: 1,111 TumGard buyers who had undergone a scope. Their results tell a story about what chronic gastritis looks like in the Indian population — and how rarely the lining is actually examined before a PPI is prescribed.

24%
confirmed gastritis on endoscopy
265 of 1,111 TumGard buyers who were scoped
86%
had a clinically significant finding
Only 5.8% — 1 in 17 — came back fully normal
62%
H. pylori positive in the same cohort
689 of 1,111 — most cases of gastritis had this driver
37%
symptomatic for over 3 years
822 of 2,208 buyers — chronic, not occasional
54%
on medication and still symptomatic
Antacids and PPIs — suppressing acid, not repairing lining
67%
suffering for over a year
1,486 of 2,208 buyers — most had been medicated throughout

How the stomach lining repairs itself — and what chronic inflammation blocks

Gastritis recovery is not passive. The stomach has to actively rebuild — and that process has specific biological requirements. These two articles explain the repair mechanism in plain language, and the inflammatory cascade that continuously works against it.

The science
How the Stomach Lining Repairs Itself — The EGFR/ERK Pathway, Explained
Goblet cells, prostaglandins, and the EGFR/ERK signalling cascade — how they work together to rebuild the mucosal barrier, and what disrupts each component in active gastritis.
The science
The Role of Inflammation in Gastritis — Why Reducing Acid Isn't Enough
NF-kB, IL-8, and the inflammatory cytokine cascade H. pylori triggers. Why suppressing acid leaves this entirely intact — and what specifically reduces chronic gastric inflammation.

Choosing the right support — honest comparisons for gastritis recovery

Supplement guide
Best Supplement for Gastritis in India 2026
TumGard, zinc carnosine, DGL licorice, and probiotics compared by mechanism — mucosal repair activity, anti-inflammatory evidence, H. pylori specificity, and dose data.
Comparison
TumGard vs Antacids for Gastritis: What's Actually Different
Antacids neutralise acid. TumGard targets the H. pylori activity driving the inflammation and supports the mucosal repair pathway. For chronic gastritis, these are not competing options — they solve different problems.
🔗
Related guide
H. Pylori & Gastritis — Complete Guide
Since H. pylori is the primary cause of chronic gastritis in India, the H. pylori articles are directly relevant — particularly the urease mechanism, flavonoid science, and antibiotic resistance context. These two guides are designed to be read together.
Read the H. Pylori & Gastritis guide →

Of the 1,111 TumGard buyers who underwent endoscopy, 24% received a confirmed gastritis diagnosis, 62% tested positive for H. pylori — most of these overlapping — and only 5.8% had a fully normal result. The 86% clinically significant finding rate in a population that had been managing symptoms with antacids and PPIs is the central finding behind this guide: most Indians with persistent gut symptoms who actually look have something structural. Most are never given the chance to look.

TumGard India Gut Health Report 2026 · n = 1,111 (endoscopy sub-cohort) · tumgard.com/india-gut-health-report-2026

QUESTIONS

Frequently asked questions about chronic gastritis.

The most common cause of chronic gastritis in India is H. pylori infection. In TumGard's survey, 62% of endoscoped buyers tested H. pylori positive and 24% had confirmed gastritis — these findings overlap significantly because H. pylori is the leading driver of chronic active gastritis. Other causes include long-term NSAID use, alcohol, autoimmune conditions, and chronic stress.
When caused by H. pylori, chronic active gastritis can resolve after successful eradication of the bacteria. However, the stomach lining takes weeks to months to structurally repair after the inflammation resolves. Supporting mucosal recovery with flavonoid compounds — which activate the EGFR/ERK repair pathway and stimulate protective mucus production — accelerates the structural healing process.
The most common symptoms are: burning or aching in the upper stomach (particularly when the stomach is empty), persistent nausea, loss of appetite, bloating after small meals, chronic belching, and early satiety — feeling full very quickly when eating. These symptoms overlap almost entirely with ordinary acidity, which is why most patients with gastritis are given antacids that don't address the underlying inflammation.
Minor gastric irritation can settle within weeks. Genuine chronic gastritis — with mucosal thinning, goblet cell damage, and persistent inflammation — takes 60–90 days of consistent support for meaningful recovery. This assumes the underlying cause (usually H. pylori) is being addressed simultaneously.
No — but they share causes and can coexist. Gastritis is inflammation of the stomach lining. A peptic ulcer is a physical break in the lining — an erosion that penetrates deeper than the surface layers. Chronic untreated gastritis, particularly H. pylori-driven, can progress to ulceration over time.
Yes — through specific mechanisms. Licorice-derived flavonoids activate the EGFR/ERK mucosal repair pathway and stimulate goblet cells to produce more protective mucus. Quercetin inhibits the NF-kB inflammatory signalling cascade that H. pylori triggers — directly reducing the cytokine production that damages gastric tissue. TumGard delivers 700mg of these flavonoids per serving.
Substances that most consistently worsen gastritis: regular NSAID use (ibuprofen, diclofenac — these directly inhibit prostaglandin synthesis and damage the mucosal barrier), alcohol, coffee on an empty stomach, and large meals. Cold milk provides momentary relief but stimulates more acid production within 30–60 minutes — its protein content drives gastrin release.

MADE RIGHT

Independently tested. Every batch.

Doctors Analytical Lab, Thane — NABL certified. Not self-declared.

Production Facility
Manufacturing facility — production line interior
FSSAI Licensed
License no. 13220010000104. Regulated by the Food Safety and Standards Authority of India.
View License →
Lab Testing
Preservative analysis — Doctors Analytical Lab, Thane
Preservative Free
Every batch tested and certified free of artificial preservatives at Doctors Analytical Lab, Thane — NABL certified.
View Report →
Chemical Testing
Heavy metal analysis — lead, arsenic, cadmium, mercury, chromium
Heavy Metal Free
Tested for lead, arsenic, cadmium, mercury and chromium. All within safe limits. Every batch, not just once.
View Report →
Microbial Testing
Safety testing — total plate count, yeast, mould and pathogens
Microbially Safe
Tested for total plate count, yeast, mould and pathogens. Certified safe for consumption. Every batch.
View Report →
TUMGARD PLUS

Gastritis needs more than an antacid. It needs the lining addressed.

TumGard Plus is a 60-day plant-flavonoid protocol for H. pylori and chronic gastritis. Targets the inflammation, supports mucosal repair. 60-day money-back guarantee.

Start the Protocol → 60-day money-back guarantee · Free delivery across India
🔬 PMC-indexed science 🏭 NABL certified testing 🛡️ 60-day money-back guarantee 📦 Ships in 24 hours
CLINICAL AUTHOR
Merlin Annie Raj
Registered Dietitian · IDA Reg. No. 013/2011

Registered Dietitian with the Indian Dietetic Association. Clinical author and data compiler of the TumGard India Gut Health Report 2026, overseeing clinical accuracy across 20,363 respondents.

✓ IDA Registered Dietitian
REVIEWED BY Harsh Doshi
Founder, Hugg Beverages

Founder of Hugg Beverages and principal investigator of the TumGard gut health survey programme. Reviewed this guide for scientific accuracy and editorial consistency.

✓ Verified Certificate — Principles of Biochemistry (edX)

References

  1. Crowe SE. Helicobacter pylori infection. New England Journal of Medicine. 2019;380(12):1158–1165. PubMed: PMID 30699316.Authoritative clinical review establishing H. pylori as the primary cause of chronic active gastritis worldwide — the foundational relationship underpinning this guide's central argument.
  2. Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defence and cytoprotection: bench to bedside. Gastroenterology. 2008;135(1):41–60. PubMed: PMID 18424695.Comprehensive review of gastric mucosal defence mechanisms — goblet cells, prostaglandins, mucus layer, EGFR/ERK pathway. The mechanistic basis for the repair and inflammation articles in this guide.
  3. Xiao ZP et al. Quercetin as inhibitor of H. pylori urease. European Journal of Medicinal Chemistry. 2006;41(4):493–499. PubMed: PMID 16887239.Documents quercetin and myricetin as H. pylori urease inhibitors — directly relevant to disrupting the bacterial driver of gastritis at the source.
  4. Ye YN, Liu ES, Shin VY, Wu WK, Cho CH. Licorice flavonoids and gastric mucosal repair via EGFR/ERK signalling. Journal of Ethnopharmacology. 2023. PubMed: PMID 36842733.Documents licorice flavonoid activity via EGFR/ERK pathway and NF-kB inhibition in gastric mucosal repair. The mechanistic evidence base for TumGard's role in gastritis recovery.
How our data compares to published literature

The 24% gastritis confirmation rate in TumGard's endoscopy cohort (n=1,111) reflects a self-selected population of people with persistent gut symptoms — not a random population sample. Published endoscopy studies in symptomatic Indian patients report H. pylori-associated gastritis in 40–70% of cases, consistent with the 62% H. pylori positivity seen in the same cohort. The 86% significant finding rate is consistent with evidence that endoscopy in symptomatic Indian patients rarely returns entirely normal results. The 37% rate of suffering for over three years reflects the documented disconnect between acid suppression and mucosal repair — patients managed rather than healed. All flavonoid mechanism claims are grounded in PMC-indexed peer-reviewed literature cited above.